Post Market Surveillance (PMS) for Medical Devices
Post Market Surveillance (PMS) is a foundational requirement in the medical device lifecycle ensuring devices remain safe, effective, and reliable long after market launch. As global regulations such as EU MDR, IVDR, and FDA post market rules become increasingly stringent, manufacturers must continuously monitor real world device performance, detect emerging risks early, and maintain proactive vigilance across global markets.
Masuu Global Solutions provides end to end PMS support, helping medical device companies manage everything from complaint handling to PMSR/PSUR/PMCF documentation. Our rigorous, structured PMS programs enable manufacturers to remain compliant, audit ready, and competitive while maintaining patient safety and regulatory confidence.
Why Post Market Surveillance Matters
As medical technology evolves spanning SaMD, wearables, Ai enabled systems, and cloud connected devices—the regulatory expectations around real world monitoring have intensified. PMS is essential because:- Advanced Devices Require Continuous Monitoring Modern devices generate complex data and often interact with multiple technologies, making ongoing assessment of safety, performance, and usability vital.
- Regulatory Demands Are Increasing EU MDR/IVDR mandates comprehensive PMS plans, periodic safety updates, PMCF/PMPF activities, signal detection, and real world evidence integration.
- Real World Evidence (RWE) is Now Central Regulators increasingly rely on RWE, such as patient reported outcomes and digital vigilance, to assess long term safety and performance.
- Early Risk Identification Reduces Cost & Impact Trend analysis, signal detection, and Health Hazard Evaluations (HHE) help prevent incidents and reduce the likelihood of recalls or regulatory enforcement.
- Fragmented data sources
- Multilingual complaint channels
- Region-specific reporting timelines
- Technical complexity in PMS documentation
- Difficulties maintaining consistency across global markets
Masuu Global Solutions addresses these challenges with structured methodologies, specialized expertise, and automated analytical tools to ensure you remain fully compliant.
Key Components of Post Market Surveillance
Effective PMS integrates several interconnected activities that together support global regulatory compliance:- Complaint & Adverse Event Management Structured intake, categorization, investigation, and trending of complaints to detect potential risks early and ensure compliance with FDA, MDR, and other vigilance systems.
- Vigilance & Regulatory Reporting Timely and accurate reporting of serious incidents to regulators worldwide, supported by risk evaluation and medical review to ensure ongoing patient safety.
- Recalls, Corrections & Field Safety Actions Comprehensive management of field corrective actions (FSCAs), including communication, regulatory notifications, HHE reports, and effectiveness checks.
- PMS Plan (PMSP) A strategy document outlining roles, processes, and data sources for collecting and analyzing post market device data.
- PMSR, PSUR & PMCF Documentation Regulatory mandated reports summarizing benefit–risk status, clinical updates, and ongoing follow-up studies.
- Trend Reporting & Real World Evidence Structured analysis of safety signals, performance trends, and real world usage data, enabling proactive decision making and CAPA triggers.
Masuu’s Post Market Surveillance Services
- Product complaints management
- Device recalls, field corrections & removals
- PMS Plans (PMSP), PMSR, PMCF, PSUR, Annual PMS maintenance
- Health Hazard Evaluation (HHE)
- Multilingual medical device translation services
Why Partner with Masuu Global Solutions?
- Global Regulatory Alignment Expertise across FDA, EU MDR/IVDR, APAC, and other regional PMS frameworks ensures consistent, audit ready compliance.
- End-to-end PMS Lifecycle Management From complaint intake to PSUR creation, Masuu manages every PMS requirement with precision and speed.
- Technology Enabled PMS AI supported analytics and automated trending systems enable early detection of emerging risks and data driven decision making.
- Multilingual Capability Local language specialists streamline complaint triage and regulatory submissions across global markets.
- Proven Regulatory Success Masuu has extensive experience supporting companies through notified body audits, FDA inspections, and global PMS reviews—with reduced findings and consistently strong compliance outcomes.
Frequently Asked Questions
Post-market surveillance is the ongoing collection and evaluation of information about a medical device after it enters the market. It monitors real-world safety, performance, and usability and helps identify emerging risks. PMS activities can include complaint management, vigilance reporting, trend analysis, field actions, and periodic regulatory reporting.
PMS helps manufacturers continue monitoring device safety and performance after market launch. It provides a structured way to identify complaints, adverse events, emerging risks, and performance trends. The information can support regulatory reporting, risk evaluation, corrective actions, and ongoing assessment of the device throughout its lifecycle.
PMS can involve information from product complaints, adverse events, real-world device use, safety signals, performance trends, and other post-market data sources. The collected information is analyzed to identify potential risks and changes in the device’s safety or performance profile. Different markets may also have specific reporting requirements.
A Post-Market Surveillance Plan is a strategy document that defines how post-market device information will be collected and analyzed. It can outline relevant roles, processes, and data sources used for surveillance. The plan provides a structured framework for monitoring device safety, performance, and emerging risks after commercialization.
Complaint management can involve structured intake, categorization, investigation, and trending of complaints. Reviewing complaint information helps identify potential safety or performance concerns and determine whether further investigation or regulatory action may be necessary. Complaint data can also contribute to broader PMS analyses and risk assessments.
Vigilance reporting involves communicating relevant safety incidents and other reportable events to regulatory authorities according to applicable requirements. The source describes timely reporting of serious incidents, supported by risk evaluation and medical review. Specific reporting requirements and timelines can differ between regulatory jurisdictions.
PMSR and PSUR are periodic regulatory reports used to summarize post-market safety and performance information. The source describes these reports as covering aspects such as benefit-risk status, clinical updates, and relevant follow-up information. The applicable report and requirements depend on the regulatory framework governing the medical device.
Trend reporting involves analyzing safety signals and performance trends identified from post-market information. It can help detect patterns that may require further assessment or action. The source also identifies trend analysis as a potential trigger for CAPA activities, linking PMS findings with broader quality and risk-management processes.
Recalls, corrections, and field safety corrective actions are measures used to address identified device-related issues after products have reached the market. PMS activities can include managing communications, regulatory notifications, Health Hazard Evaluation reports, and effectiveness checks associated with these field actions.
Real-world evidence can provide information about how medical devices perform and are used under actual conditions after market introduction. The source identifies patient-reported outcomes and digital vigilance as examples of real-world information that can contribute to long-term safety and performance assessment and broader PMS decision-making.